- Filed
- Aug 22, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Aug 18, 2025 | 58.93M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 57.31M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 42.53M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$92.49K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$88.57K |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $1.19M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $1.51M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$682.52K |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$856.17K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$2.07M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$1.98M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.37M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.7M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $3.18M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.5M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.92M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $2.07M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.5M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.65M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$0.01 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$0.01 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $872.8K |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $498.2K |
| Net Income | Q1 2025 · Mar 31, 2025 | −$560.23K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$161.98K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$523.88K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$144.43K |
| Gross Profit | Q1 2025 · Mar 31, 2025 | $348.92K |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $353.77K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $127.79K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $273.98K |
| Revenue | Q1 2025 · Mar 31, 2025 | $476.71K |
| Revenue | Q1 2025 · Mar 31, 2024 | $627.75K |